(Q44464099)

3 December 2017

Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study (English)

1 reference

3 December 2017

0 references

0 references

Stephan A Chalon

1

1 reference

3 December 2017

Luc-André Granier

2

1 reference

3 December 2017

François R Vandenhende

3

1 reference

3 December 2017

Peter R Bieck

4

1 reference

3 December 2017

Frank P Bymaster

5

1 reference

3 December 2017

Melissa J Joliat

6

1 reference

3 December 2017

Christine Hirth

7

1 reference

3 December 2017

William Z Potter

8

1 reference

3 December 2017

language of work or name

English

0 references

publication date

28 May 2003

1 reference

3 December 2017

Neuropsychopharmacology

1 reference

3 December 2017

28

1 reference

3 December 2017

9

1 reference

3 December 2017

1685-1693

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300209

3 December 2017

0 references

cites work

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

The tyramine pressor test may have limited sensitivity, especially in the presence of dual serotonin/norepinephrine uptake inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Studies of the interaction of desmethylimipramine with tyramine in man after a single oral dose, and its correlation with plasma concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Intravenous tyramine pressor response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Cardiovascular Effects of Tricyclic Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

A comparison of diclofensine and desmethylimipramine using tyramine pressor tests in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Influence of nomifensine and desipramine on tyramine pressor responses in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Oxaprotiline: enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not alpha 2-adrenoceptor binding to intact platelets in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Duloxetine (LY 248686): an inhibitor of serotonin and noradrenaline uptake and an antidepressant drug candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

LY248686, a new inhibitor of serotonin and norepinephrine uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Assay of urinary free and conjugated 3-methoxy-4-hydroxyphenylethyleneglycol by high-performance liquid chromatography with amperometric detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Beta-blockade antagonism of tyramine-induced rise in blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Evidence of the dual mechanisms of action of venlafaxine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Whole blood serotonin and plasma tryptophan using high-pressure liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Evaluation of methods of administering tyramine to raise systolic blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Determination of free urinary catecholamines by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300209

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300209

1 reference

3 December 2017

1 reference